Disciplined Growth Investors Inc Coherus Bio Sciences, Inc. Transaction History

Disciplined Growth Investors Inc

$4.6 Billion
Q4 2024

A detailed history of Disciplined Growth Investors Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Disciplined Growth Investors Inc holds 566,746 shares of CHRS stock, worth $606,418. This represents 0.02% of its overall portfolio holdings.

Number of Shares

566,746

Previous 766,308 26.04%

Holding current value

$606,418

Previous $796,000 1.76%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.71 $133,706 - $341,251	-199,562 Reduced 26.04%	566,746 $782,000
Q3 2024 Nov 14, 2024	SELL	$0.99 - $1.8 $485,873 - $883,405	-490,781 Reduced 39.04%	766,308 $796,000
Q2 2024 Aug 15, 2024	BUY	$1.58 - $2.51 $1,820 - $2,891	1,152 Added 0.09%	1,257,089 $2.17 Million
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $180,204 - $280,119	89,210 Added 7.65%	1,255,937 $3 Million
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $26,869 - $65,061	-16,899 Reduced 1.43%	1,166,727 $3.89 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $14,739 - $21,478	3,941 Added 0.33%	1,183,626 $4.43 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $53,715 - $117,635	14,173 Added 1.22%	1,179,685 $5.04 Million
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $130,121 - $232,407	22,092 Added 1.93%	1,165,512 $7.97 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $64,433 - $114,032	11,324 Added 1.0%	1,143,420 $9.06 Million
Q3 2022 Nov 15, 2022	BUY	$7.17 - $13.87 $6.35 Million - $12.3 Million	886,075 Added 360.16%	1,132,096 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $6,446 - $14,553	1,100 Added 0.45%	246,021 $1.78 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $96,696 - $145,310	8,855 Added 3.75%	244,921 $3.16 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $3.45 Million - $4.15 Million	-218,358 Reduced 48.05%	236,066 $3.77 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $590,273 - $702,403	45,581 Added 11.15%	454,424 $6.29 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $715,232 - $1.06 Million	-49,600 Reduced 10.82%	408,843 $5.97 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $228,047 - $260,822	-13,771 Reduced 2.92%	458,443 $7.97 Million
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $8.22 Million - $9.39 Million	472,214 New	472,214 $8.66 Million

Others Institutions Holding CHRS

# of Institutions

130

Shares Held

67.8M

Call Options Held

1.68M

Put Options Held

91.8K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $83.2M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Account

Disciplined Growth Investors Inc Coherus Bio Sciences, Inc. Transaction History